We believe pets deserve more therapeutics developed and approved specifically for them.
Only 15% of pet diseases have an approved treatment. We’re working on therapeutics for the other 85%.
Anivive Lifesciences, Inc. is a next generation animal health company.
We combine artificial intelligence software, biotech, and veterinary medicine to serve the unmet medical needs of pets with a diverse pipeline of innovative products to treat cancers, infectious diseases, and endocrine conditions.
Using proprietary software and predictive analytics, Anivive is accelerating the discovery, development, and commercialization of new, affordable treatments for pets.
Valley fever is currently not preventable — and spreading
Anivive's Valley fever vaccine demonstrated efficacy in laboratory studies and now awaits completion of a field safety study prior to submission for approval.
The vaccine is designed to be given as an injection, the same way dogs receive other vaccines, with two injections the first year, and a single booster annually.
The impact of
Valley fever is caused by a soil borne fungi that thrives in semiarid regions and is expanding across the Western US.
Reportable fungal disease in western US
Even when treated, infection can recur and cause debilitations or death
In reported cases since the year 2000, with spread linked to climate change